AK-1012

N/A

Report date: 2026/03/27 20:01:50

Base Information

Drug NameAK-1012
Drug Alias NameAK1012AK-1012
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLower Respiratory Tract InfectionsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAnhui Anke Biotechnology (Group) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Anke Biotechnology (Group) Co Ltd
Inactive CompaniesN/A
Active IndicationsLower Respiratory Tract InfectionsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A